FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

395934003: Anthraquinone glycoside (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1469874015 Anthraquinone glycoside (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1489567013 Anthraquinone glycoside en Synonym Active Entire term case insensitive SNOMED CT core module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Anthraquinone glycoside Is a Anthraquinone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Salicylic acid+anthraquinone glycosides 1%/0.5% oral paint Has active ingredient False Anthraquinone glycoside Inferred relationship Existential restriction modifier
Cascara Is a True Anthraquinone glycoside Inferred relationship Existential restriction modifier
Product containing only anthraquinone glycoside and salicylic acid (medicinal product) Has active ingredient True Anthraquinone glycoside Inferred relationship Existential restriction modifier 2
Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) Has active ingredient True Anthraquinone glycoside Inferred relationship Existential restriction modifier 2
Product containing anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) Has active ingredient True Anthraquinone glycoside Inferred relationship Existential restriction modifier 2
Product containing anthraquinone glycoside and salicylic acid (medicinal product) Has active ingredient True Anthraquinone glycoside Inferred relationship Existential restriction modifier 2
Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) Has precise active ingredient True Anthraquinone glycoside Inferred relationship Existential restriction modifier 2
Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) Has basis of strength substance True Anthraquinone glycoside Inferred relationship Existential restriction modifier 2
Salicylic acid+anthraquinone glycosides 1%/0.5% oral paint - product Has active ingredient False Anthraquinone glycoside Inferred relationship Existential restriction modifier
Pyralvex oral paint Has active ingredient False Anthraquinone glycoside Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start